# A Study of Monepantel in Individuals With Motor Neurone Disease

> **NCT04894240** · PHASE1 · COMPLETED · sponsor: **Neurizon Therapeutics Limited** · enrollment: 12 (actual)

## Conditions studied

- Motor Neuron Disease

## Interventions

- **DRUG:** Monepantel

## Key facts

- **NCT ID:** NCT04894240
- **Lead sponsor:** Neurizon Therapeutics Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-28
- **Primary completion:** 2023-11-29
- **Final completion:** 2023-11-29
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-12-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04894240

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04894240, "A Study of Monepantel in Individuals With Motor Neurone Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04894240. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*